➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
AstraZeneca
Merck
Johnson and Johnson
Express Scripts

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for JZP-110


Email this page to a colleague

« Back to Dashboard

What is the drug development status for JZP-110?

JZP-110 is an investigational drug.

There have been 11 clinical trials for JZP-110. The most recent clinical trial was a Phase 1 trial, which was initiated on May 1st 2015.

The most common disease conditions in clinical trials are Narcolepsy, Disorders of Excessive Somnolence, and Sleep Apnea, Obstructive. The leading clinical trial sponsors are Jazz Pharmaceuticals, Children's Oncology Group (COG), and Concert Pharmaceuticals.

There are thirty-six US patents protecting this investigational drug and two hundred and sixty-three international patents.

Recent Clinical Trials for JZP-110
TitleSponsorPhase
An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)Children's Oncology Group (COG)Phase 2/Phase 3
An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)Jazz PharmaceuticalsPhase 2/Phase 3
A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety ExtensionJazz PharmaceuticalsPhase 3

See all JZP-110 clinical trials

Clinical Trial Summary for JZP-110

Top disease conditions for JZP-110
Top clinical trial sponsors for JZP-110

See all JZP-110 clinical trials

US Patents for JZP-110

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
JZP-110 ⤷  Try it Free Treatment for obesity Jazz Pharmaceuticals International III Limited (Hamilton, BM) SK Biopharmaceuticals Co., Ltd. (Seoul, KR) ⤷  Try it Free
JZP-110 ⤷  Try it Free Formulations of (R)-2-amino-3-phenylpropyl carbamate Jazz Pharmaceuticals International III Limited (Hamilton, BM) ⤷  Try it Free
JZP-110 ⤷  Try it Free Methods for treating attention-deficit/hyperactivity disorder SK Biopharmaceuticals Co., Ltd. (Seongnam-si, Gyeonggi-do, KR) ⤷  Try it Free
JZP-110 ⤷  Try it Free Treatment of cataplexy Jazz Pharmaceuticals International III Limited (Hamilton, BM) SK Biopharmaceuticals Co., Ltd. (Seoul, KR) ⤷  Try it Free
JZP-110 ⤷  Try it Free Aminocarbonylcarbamate compounds SK BIOPHARMACEUTICALS CO., LTD. (Seoul, KR) ⤷  Try it Free
JZP-110 ⤷  Try it Free Treatment of sleep-wake disorders SK Biopharmaceuticals Co., Ltd. (Seongnam-si, Gyeonggi-do, KR) ⤷  Try it Free
JZP-110 ⤷  Try it Free Aminocarbonylcarbamate compounds SK BIOPHARMACEUTICALS CO., LTD. (Gyeonggi-do, KR) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for JZP-110

Drugname Country Document Number Estimated Expiration Related US Patent
JZP-110 Canada CA2917702 2033-07-18 ⤷  Try it Free
JZP-110 China CN105873576 2033-07-18 ⤷  Try it Free
JZP-110 China CN110638804 2033-07-18 ⤷  Try it Free
JZP-110 Denmark DK3021838 2033-07-18 ⤷  Try it Free
JZP-110 European Patent Office EP3021838 2033-07-18 ⤷  Try it Free
JZP-110 Spain ES2812586 2033-07-18 ⤷  Try it Free
JZP-110 Japan JP2016532679 2033-07-18 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Mallinckrodt
Baxter
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.